Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells
Yanju Wu, Qianqian Zheng, Yan Li, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer
Ming Chi, Jiao Liu, Chenxue Mei, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 99
Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing
Hua Yu, Yue Zheng, Yiran Yao, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 96
Metformin as anticancer agent and adjuvant in cancer combination therapy: Current progress and future prospect
Lin Zhu, Kaiqing Yang, Zhe Ren, et al.
Translational Oncology (2024) Vol. 44, pp. 101945-101945
Open Access | Times Cited: 18
The Hippo Signaling Pathway in Cancer: A Cell Cycle Perspective
Yi Xiao, Jixin Dong
Cancers (2021) Vol. 13, Iss. 24, pp. 6214-6214
Open Access | Times Cited: 59
Hippo Signaling in the Ovary: Emerging Roles in Development, Fertility, and Disease
Kendra L. Clark, Jitu W. George, Emilia Przygrodzka, et al.
Endocrine Reviews (2022) Vol. 43, Iss. 6, pp. 1074-1096
Open Access | Times Cited: 55
Current Status and Prospects of Clinical Treatment of Osteosarcoma
Zong-Yuan Jiang, Ji‐Bin Liu, Xiaofeng Wang, et al.
Technology in Cancer Research & Treatment (2022) Vol. 21
Open Access | Times Cited: 44
Punicalagin Inhibits Cell Growth and Promotes Apoptosis in Bladder Cancer T24 Cells via Upregulating Oxidative Stress and Apoptotic Marker Expressions
Junqing Gu, Tommaso Cai, Yugen Li, et al.
Indian Journal of Pharmaceutical Education and Research (2025) Vol. 59, Iss. 1, pp. 112-121
Closed Access | Times Cited: 1
Metformin inhibits hepatocellular carcinoma development by inducing apoptosis and pyroptosis through regulating FOXO3
Zetian Shen, Han Zhou, Ao‐Mei Li, et al.
Aging (2021) Vol. 13, Iss. 18, pp. 22120-22133
Open Access | Times Cited: 42
TEAD4 is a master regulator of high-risk nasopharyngeal carcinoma
Ya-Qin Wang, Donghong Wu, Denghui Wei, et al.
Science Advances (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 19
Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review
Yi Zhang, Fang Zhou, Jiaheng Guan, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 250-250
Open Access | Times Cited: 19
Berberine targets KIF20A and CCNE2 to inhibit the progression of nonsmall cell lung cancer via the PI3K/AKT pathway
Qi Wang, Hua Wu, Qingquan Wu, et al.
Drug Development Research (2023) Vol. 84, Iss. 5, pp. 907-921
Closed Access | Times Cited: 17
Effects of metformin on cancers in experimental and clinical studies: Focusing on autophagy and AMPK/mTOR signaling pathways
Mohammad Yasin Zamanian, Maryam Golmohammadi, Alexey Yumashev, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 4
Open Access | Times Cited: 8
Natural compounds targeting YAP/TAZ axis in cancer: Current state of art and challenges
Aviral Kumar, Bandari BharathwajChetty, Mukesh Kumar Manickasamy, et al.
Pharmacological Research (2024) Vol. 203, pp. 107167-107167
Open Access | Times Cited: 7
CoenzymeQ10-Induced Activation of AMPK-YAP-OPA1 Pathway Alleviates Atherosclerosis by Improving Mitochondrial Function, Inhibiting Oxidative Stress and Promoting Energy Metabolism
Tianqi Xie, Changyuan Wang, Yue Jin, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 49
PTPRD-inactivation-induced CXCL8 promotes angiogenesis and metastasis in gastric cancer and is inhibited by metformin
Won Jung Bae, Ji Mi Ahn, Hye-Eun Byeon, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 44
Yes-associated protein and transcriptional coactivator with PDZ-binding motif as new targets in cardiovascular diseases
Yue Yu, Xingli Su, Qiaohong Qin, et al.
Pharmacological Research (2020) Vol. 159, pp. 105009-105009
Closed Access | Times Cited: 41
<p>Structural and Functional Overview of TEAD4 in Cancer Biology</p>
Mu Chen, Bingsong Huang, Lei Zhu, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 9865-9874
Open Access | Times Cited: 41
The Epithelial to Mesenchymal Transition Related Gene Calumenin Is an Adverse Prognostic Factor of Bladder Cancer Correlated With Tumor Microenvironment Remodeling, Gene Mutation, and Ferroptosis
Yiheng Du, WenHao Miao, Xiang Jiang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 39
Metformin: review of epidemiology and mechanisms of action in pancreatic cancer
Guido Eibl, Enrique Rozengurt
Cancer and Metastasis Reviews (2021) Vol. 40, Iss. 3, pp. 865-878
Open Access | Times Cited: 38
New insights into the Hippo/YAP pathway in idiopathic pulmonary fibrosis
Mingyao Sun, Yangyang Sun, Ziru Feng, et al.
Pharmacological Research (2021) Vol. 169, pp. 105635-105635
Closed Access | Times Cited: 34
Repurposing of Metabolic Drugs Metformin and Simvastatin as an Emerging Class of Cancer Therapeutics
Santosh K. Maurya, Smriti Chaudhri, Shashank Kumar, et al.
Pharmaceutical Research (2025)
Closed Access
Targeting m6A RNA Modification in Tumor Therapeutics
Zhenwei Mao, Min Li, Shengjun Wang
Current Oncology (2025) Vol. 32, Iss. 3, pp. 159-159
Open Access
CCNE2 promotes cisplatin resistance and affects prognosis of head and neck squamous cell carcinoma by targeting MNAT1
Ran An, Xiaolin Xu, Yue Wang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
RETRACTED: YAP1 Inhibition in HUVECs Is Associated with Released Exosomes and Increased Hepatocarcinoma Invasion and Metastasis
Yan Li, Xiaodong Zhang, Qianqian Zheng, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 21, pp. 86-97
Open Access | Times Cited: 29
ΔNp63α in cancer: importance and therapeutic opportunities
Matthew L. Fisher, Seamus Balinth, Alea A. Mills
Trends in Cell Biology (2022) Vol. 33, Iss. 4, pp. 280-292
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top